Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Optim V

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-300-01 D-0427-2025
Class II · Moderate risk

Kofal

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-109-02 D-0426-2025
Class II · Moderate risk

KOFAL Original

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-106-04 D-0425-2025
Class II · Moderate risk

Kingskin

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-423-15 D-0424-2025
Class II · Moderate risk

Cura Hongos

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited D-0423-2025
Class II · Moderate risk

Cura Hongos

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited D-0422-2025
Class II · Moderate risk

Clindamycin HCl Capsule

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Ongoing cGMP deviation RemedyRePack Inc. D-0411-2025
Class II · Moderate risk

Urodel

cGMP deviations

Terminated cGMP deviation Pharmadel, LLC NDC 55758-406-30 D-0384-2025
Class II · Moderate risk

Kingskin

cGMP deviations

Terminated cGMP deviation Pharmadel, LLC NDC 55758-409-15 D-0381-2025
Class II · Moderate risk

Testosterone Cypionate Injection

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Ongoing cGMP deviation Eugia US LLC NDC 55150-277-01 D-0363-2025
Class II · Moderate risk

Voriconazole Tablets

cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.

Terminated cGMP deviation Amerisource Health Services LLC NDC 60687-294-21 D-0307-2025